Efficacy of Sodium Bicarbonate Infusion in Reversal of Acute Renal Failure 1 NEPHRO 2014 June 25-28, 2014 Valencia, Spain.

Slides:



Advertisements
Similar presentations
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Advertisements

Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
FY1 Teaching Nov 30th 2011 Dr Jack Bond ST5 Nephrology
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
Lesley Stevens MD Tufts-New England Medical Center
Kidney Function Tests Rana Hasanato, MD, KSFCB
Kidney Function Tests Contents: Functional units Kidney functions Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
1 Diabetes Education Teaching Guide Kidney Health.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
RENAL DISEASE IN DIABETES
CHRONIC RENAL FAILURE JAKUB ZÁVADA KLINIKA NEFROLOGIE 1.LF UK.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Case 6 A 54 year old obese person come in emergency with altered consciousness level and increase respiratory rate (tachypnia) for last 4 hours. He is.
Diabetic Ketoacidosis DKA)
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study) Lambers Heerspink,
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Aminoglycoside-Induced Acute Tubular Necrosis PHCL 442 Lab Discussion 2 Raniah Al-Jaizani M.Sc.
Section 5: Configuration of healthcare to manage CKD.
CONTROL OF DELTA(D) GLUCOSE WITH INTENSIVE INSULIN THERAPY IS FUNDAMENTAL TO RENAL PRESERVATION IN DIABETES 1 [1] Endocrinology 2014 Chicago, Illinois.
Kidney Function Tests.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case: HYPERKALEMIA Group A2.
Management of diabetic ketoacidosis Prof. M.Alhummayyd.
Renal Disease Normal Anatomy andPhysiology. Renal: Normal Anatomy 1. Renal artery and vein: 25% of blood volume passes through the kidney / minute 2.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Management of diabetic ketoacidosis (DKA) Prof. M.Alhummayyd.
Acute Diabetes Case B By: Abdullah Osman Christine Tanzil Ayse Togac.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
HTN Cases Pharmacotherapy - 1. Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Selected aspects of acid base physiology- acidosis in CKD
Acute and Chronic Renal Failure By Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Hyperkalemia Severe: above 6.5 mmol/l carry
Chapter 37 Chronic Kidney Disease: The New Epidemic
1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Date of download: 5/28/2016 From: New Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study Ann Intern Med. 2012;156(8):
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S Bianchi, R Bigazzi and VM Campese Kidney.
Risk Involved with Dual RAAS Blockade in Kidney Disease Source: Bakris GL. Dual RAAS blockade is desirable in kidney disease: Con. Kidney Int. 2010;78:546–549.
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Angiotensin-Converting Enzyme Inhibitor–Associated.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
The LIVES Sub-analysis
Copyright © 2015 by the American Osteopathic Association.
Baseline characteristics and effectiveness results
Diuretics Thiazides are the preferred type of diuretic for treating hypertension, and all are equally effective in lowering blood pressure. In patients.
Robert C. Stanton, MD  American Journal of Kidney Diseases 
2017 Annual Data Report Healthy People 2020.
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Management of diabetic ketoacidosis
HTN Cases Pharmacotherapy - 1.
Protocol for the management of adult patients with DKA
Acute and Chronic Renal Failure
Diuretics, Kidney Diseases Urine R&M
2018 Annual Data Report Volume 3: Healthy People 2020
Nat. Rev. Nephrol. doi: /nrneph
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Protocol for the management of adult patients with HHS
Nat. Rev. Cardiol. doi: /nrcardio
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Protocol for the management of adult patients with DKA
Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.
Presentation transcript:

Efficacy of Sodium Bicarbonate Infusion in Reversal of Acute Renal Failure 1 NEPHRO 2014 June 25-28, 2014 Valencia, Spain

INTRODUCTION 1. Acute kidney injury or acute renal failure (ARF) has been cited as a major factor that may contribute to end stage renal disease (ESRD) in diabetes. 2. Any episode of ARF was risk a factor for chronic Kidney disease (CKD) stage 4 (HR 3.56) 3. Each ARF episode doubled that risk [1] [1] Thakkar CV et al. Acute Kidney Injury episodes and Chronic Kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 2011; 6: [2]

INTRODUCTION (cont.) 4. Aggressive blood pressure –lowering treatment approaches with angiotensin converting enzymes inhibitors (ACEI) and angiotensin receptor blockers (ARB) may contribute to ARF episodes and enhance CKD progression [2] Onuigbo MA, can ACE inhibitor and angiotensin receptor blockers be detrimental in CKD patients. Nephro Clin Pract 2011; 118: C [3]

 Angiotensin Converting Enzyme Inhibitor (ACEI) Most Common: Lisinopril (70 percent)  Angiotensin Receptor Blocker (ARB) Most Common: Valsartan (Diovan) Intention: To decrease proteinuria and thus reduce the risk of ESRD. Irony: With prevalent and indiscriminate use of ACEI / ARB, the incidence of ESRD has increased over the years. [4]

YearESRD – Dialysis (number of Patients) , , ACEI entered the market as a renoprotective drug , , , , Projection: 750,000 Americans will have ESRD 5 [5] Why?

PURPOSE OF PRESENTATION 1.This presentation is intended to demonstrate that ARF is reversible with appropriate therapy. 2. Our aim is to determine the effectiveness of sodium bicarbonate infusion in reversal of ARF [6]

MATERIALS AND METHODS 1.Any patients with ARF should be treated with sodium bicarbonate infusion 2.ARF is defined by increase of serum creatinine by more than 0.5 mg/dl from the baseline. 3.Concomitant metabolic acidosis and hyperkalemia are important prerequisites to the success of bicarbonate infusion. [7]

METHODS (cont.) 1.Bicarbonate infusion is prepared by mixing sodium bicarbonate 50, 100 or 150 mEQ in a liter of isotonic saline solution (0.9 % NaCl), half normal (0.45 % NaCl ) or 5% dextrose solution. While isotonic or half normal saline may be preferable in diabetics, 5 % dextrose solution is preferred in non-diabetics. [8]

METHODS (cont.) 2. No information on infusion rate available. However, rate varies from 75 to 100ml/hour for 48 hours depending on blood pressure level and severity of metabolic acidosis then at a reduced rate for another hours until C02 level (Renal Panel) reaches near normal to normal. [9]

Study In Support of Bicarbonate Therapy in ARF/CKD O Bicarbonate supplementation slows progression of CKD and improves nutritional status. Ione de Brito-Ashurst, et al, J Am Soc Nephrol 2009;20: [10]

DATA OF PATIENTS ARE TESTIMONIAL TO THAT EFFECT. Table 1. Serial Laboratory Studies in a 59 year old African American Male with a long History of Diabetes Mellitus. Admitted to Hospital for Acute Renal Failure F = Fasting, BUN = blood urea nitrogen, Scr = serum creatinine Date 2005Glucose (F) (mg/dl) BUN (mg/dl)Scr (mEq/L)Na + (mEq/L)K+ (mEq/L)C0² (mEq/L) Aug Hospital admission: Lisinopril discontinued Aug (ph 7.31, base excess 7.7) Normal saline with 3 ampules of sodium bicarbonate infusion started. Regular insulin given subcutaneously Aug Aug Aug Discharged from hospital [11]

EFFECT OF SODIUM BICARBONATE INFUSION REVERSING ARF. Table 2 Serial Laboratory Studies in a 68 years old Caucasian female with a weakness, very low BP. Medication: Lisinopril ; Lisinopril was discontinued Date 2010 pHHC03 (mmol/L) BUN (mg/dl) Scr (mg/dl) eGFR (ml/min) UA mg/gl PO4 mg/dL Hb Nov Bicarbonate infusion started, 125 ml/ hour, then at 75ml/hour Allopurinol 300mg BID x 2 days then 300mg daily x 2 days then 150mg daily Nov ND 9.4 Decreased Bicarbonate infusion to 50ml/hour x 48 hours Nov 11 ND Reduced bicarbonate infusion to 35 ml/h x 24 hours then stopped Nov 13 ND ND Scr=serum creatinine; eGFR = estimated glomerular filtration rate; ND= not done UA=uric acid; P04=phosphorus; Hb=hemoglobin; ABG Arterial blood gas [12]

Date 2010Na (mmol/L) K+ (mmol/L) Cl (mmol/L) C02 (mmol/L) Nov 7 13:14 h 22:05 h Nov Nov Nov EFFECT OF SODIUM BICARBONATE INFUSION REVERSING ARF. Table 3- Serum Electrolytes Table 4- Renal Function Test at Baseline and Most Recent DateNa mmol/L Scr (mg/dl) eGFR ml/min C02 (mmol/L 2010 Sep Apr Scr= serum creatinine eGFR= estimated glomerular filtration rate [13]

PEARL OF WISDOM 1.Sodium Bicarbonate Infusion for 3 to 5 days is considered a promising alternative to hemodialysis in therapy of ARF 2.Try sodium bicarbonate infusion in all cases of ARF 3.ARF doesn’t necessarily progresses into CKD. [14]

PEARL OF WISDOM 4. Volume overload and hypertension are unlikely to occur with bicarbonate infusion. 5. Oral supplementation didn’t increase blood pressure or require increased dose of antihypertensive therapy. [15]

Dictum The good physician treats the disease. The great physician treats the patient who has the disease. William Osler The Cambridge History of Medicine [16]

Thank You! 17